AGEN

Agenus Inc.

Price

$7.78

return (12m)

83.06%

p/e

3.42

p/bv

-1.53

DIVIDEND YIELD

0.00%

AGEN price

Agenus

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AGEN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.81%

3 months

122.29%

1 year

83.06%

2 years

52.25%

5 years

-94.02%

10 years

-93.60%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AGEN

Valuation

P/E

3.42

Sector -4.26

Industry -4.26

P/BV

-1.53

Sector 2.11

Industry 2.11

P/Revenue (PSR)

2.37

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

1.82

Sector 1.25

Industry 1.25

P/Net Current Assets

-1.93

Sector -5.47

Industry -5.47

P/Working Capital

-2.06

Sector -1.10

Industry -1.10

EPS

2.24

Sector -1.94

Industry -1.94

BVPS

-5.02

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

99.52%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

27.28%

Sector -36.74%

Industry -36.74%

Net Profit Margins

69.29%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.20

Sector 0.03

Industry 0.03

Profitability

ROE

-44.66%

Sector -61.50%

Industry -61.50%

ROA

53.24%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

0.34

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

-1.19

Sector 0.43

Industry 0.43

Liabilities/Assets

1.40

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-14.81%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals AGEN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AGEN Agenus Inc.	$7.78	71.37%	0.00%	3.42	-1.53	-44.66%	69.29%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AGEN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Agenus

Agenus Inc.

Average Investor10 user rating

4.0 (3 people)

United States

27 years

Founded: 1999

2000

Time since IPO - 26 years

359

Employees

Agenus Inc. (United States) is listed on the Nasdaq and has a market capitalization of $314.47 million, with shareholders equity totaling $-205.85 million.

The company employs approximately 359 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Agenus Inc. reported $132.69 million in revenue, generating net income of $91.94 million.

Key financial metrics include a P/E ratio of 3.42, a price-to-book (P/B) ratio of -1.53, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AGEN.

Market cap

$314.47 million

Net worth

$-205.85 million

$-205,850,000.00

Assets

$172.69 million

$172,690,000.00

Total Shares Outstanding

41.00 million

41,000,000

Average Daily Trading Volume

$5.12 million

$5,116,479.98

Sector

Health Care

Industry

Biotechnology

AGEN

AGEN revenue and profits

Financial Results AGEN

DRAG THE FRAME TO SEE MORE DATA

AGEN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Agenus (AGEN) today?

A cotação de Agenus (AGEN) hoje está em US$ 7.78, com uma variação de 83.06% em relação ao último ano. A cotação de Agenus (AGEN) iniciou o ano negociando na casa dos US$ 3.14 e hoje está em US$ 7.78. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Agenus (AGEN) e dados de ações do Ibovespa e mercados internacionais.

Quando Agenus (AGEN) paga dividendos?

Agenus (AGEN) não distribuiu dividendos no último ano.

Is Agenus (AGEN) a good investment?

Atualmente, Agenus (AGEN) está cotada a US$ 7.78, com um P/L de 3.42, representando um desvio de -707% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 83.06 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 83.06%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Agenus (AGEN) stock?

Investir em ações de Agenus (AGEN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Agenus (AGEN) yield today?

A rentabilidade de Agenus (AGEN) foi de 8.81% no último mês, 83.06% no último ano e -94.02% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Agenus (AGEN) hoje, o investimento total seria de US$ 778.00, com base na cotação atual de US$ 7.78.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,424.21
Em 5 anos: US$ 46.52
Em 10 anos: US$ 49.79

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AGEN

Agenus Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AGEN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING AGEN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Agenus

Agenus Inc.

United States

27 years

2000

359

PROFIT X PRICE AGEN

Financial Results AGEN

AGEN cash flow

Asset, Revenue and Profit Growth - AGEN

AGEN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions